EXOCRINE AND ENDOCRINE PANCREATIC INSUFFICIENCY IN DEVELOPMENT OF ATHEROSCLEROSIS
PDF

Keywords

chronic pancreatitis type 2 diabetes mellitus, atherosclerosis, carotid intima media thickness.

How to Cite

Pylov, D., & Zhuravlyova, L. (2021). EXOCRINE AND ENDOCRINE PANCREATIC INSUFFICIENCY IN DEVELOPMENT OF ATHEROSCLEROSIS . Inter Collegas, 7(4), 159–163. https://doi.org/10.35339/ic.7.4.159-163

Abstract

Objective: To evaluate the effect of chronic pancreatitis (CP) and exocrine insufficiency of the pancreas on the carotid intima media thickness (cIMT) in patients with type 2 diabetes mellitus (DM-2). 

Materials and methods: 91 patients were examined, they were divided into groups: 1st group-patients with DM-2 (n = 31) group 2nd – DM-2 combined with CP (n = 60).  Fasting plasma glucose (FPG), HbA1c, immunoreactive insulin (IRI), HOMA-IR index, C-reactive protein (CRP), serum α-amylase and fecal-1 elastase (FE-1) were assessed.  In order to assess the thickness of the cIMT, ultrasound of the common carotid artery was performed.  The control group of healthy volunteers was representative by age and sex. 

Results: In the 1st and 2nd groups, the average value of cIMT was (1.02 ± 0.1 vs 1.21 ± 0.15) mm.  Parameters of DM-2 management in the 1st and 2nd groups were (FPG 8.18 ± 0.92vs8.57 ± 1.2) mmol / l;  HbA1c (7.23 ± 0.21vs7.49 ± 0.36)%;  IRI (20.31 ± 0.9vs22.53 ± 1.2) μIU / ml;  HOMA-IR (6.55 ± 1.5vs8.38 ± 2.2) μIU / ml * mmol / l;  PSA (1.3 ± 0.12vs6.77 ± 0.31).  HOMA-IR correlated with: CRP (r = 0.43, p <0.05 in group 1; r = 0.61, p <0.05 in group 2);  FE-1 (r = -0.55, p <0.05 of the 2nd group);  and cIMT (r = 0.42, p <0.05 in the 1st group; r = 0.53, p <0.05 in the 2nd group).  IRI have relationship with: FE-1 (r = 0.41, p <0.05 in group 1; r = -0.3, p <0.05 in group 2);  CRP (r = 0.42, p <0.05 in group 1; r = -0.28, p <0.05 in group 2); HbA1c had close relationships with cIMT (r = 0.38, p <0.05 in group 1; r = 0.51, p <0.05 in group 2).  The relationship between cIMT and CRP was related in the 2nd group (r = 0.39, p <0.05);  with α-amylase (r = 0.2, p <0.01 2nd group).  There was no significant relationship between cIMT and FE-1 in the study. 

Conclusions: Obtained data allows us to conclude that hyperinsulinemia and insulin resistance have a direct atherogenic effect on the walls of blood vessels.  It is established that the accession of the inflammatory process leads to increasing development of atherosclerotic lesions of the vessel, at the same time, the presence of exocrine dysfunction of the pancreas does not have a significant direct effect on the cIMT.

https://doi.org/10.35339/ic.7.4.159-163
PDF

References

Gubergric, N. B., Kazjulin, A. N. (2011). Metabolicheskaja pankreatologija. Doneck: Lebed', 514 s.

Komissarenko , I. A. (2009). Polimorbidnost' i metabolicheskij sindrom u pozhilyh. Klinicheskaja gerontologija, 1, 29–38.

Piciucchi, M., Capurso, G., et al. (2015). Exocrine pancreatic insufficiency in diabetic patients: prevalence, mechanisms, and treatment. Int J Endocrinol, 2015:595649. doi: 10.1155/2015/595649.

Pezzilli, R., Calculli, L. (2014). Pancreatic steatosis: Is it related to either obesity or diabetes mellitus? World J Diabetes, 5, 415–419.

Lew , D., Afghani , E., Pandol S. (2017, ). Chronic Pancreatitis: Current Status and Challenges for Prevention and Treatment. Dig Dis Sci, 62(7), 1702–1712.

Rosso, D., Carnazzo , G (2001). Atherosclerosis and pancreatic damage. Arch Gerontol Geriatr, 32(2), 95–100.

Lohr, J.M., Panic, N. (2018). The ageing pancreas: a systematic review of the evidence and analysis of the consequences. J Intern Med, 283, 446–460. DOI: 10.1111/joim.12745.

Gullo, L., Stella, A. (1982). Cardiovascular lesions in chronic pancreatitis. Digest Dis Sci, 27, 716. 9. de la Iglesia, D., Vallejo-Senra, N. et al. (2018). Pancreatic exocrine insufficiency and cardiovascular risk in patients with chronic pancreatitis: A prospective, longitudinal cohort study. J Gastroenterol Hepatol, 34(1), 277-283. doi: 10.1111/jgh.14460. Epub 2018 Sep 25. PMID: 30156337.

Carpenter, M., Sinclair, H. (2016). Carotid intima media thickness and its utility as a predictor of cardiovascular disease: a review of evidence. Cardiol Rev, 24, 70–75.

Liviakis , L., Pogue , B., Paramsothy , P. (2010). Carotid intima-media thickness for the practicing lipidologist. J Clin Lipidol, 4, 24–35.

Polak, J. F , Pencin, M. J. (2011). Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med, 365, 213–21.

Baldassarre , D., Hamsten , A (2012). Measurements of carotid intima-media thickness and. of interadventitia common carotid diameter improve prediction of cardiovascular events: results of the IMPROVE (carotid intima media thickness [IMT] and IMT-progression as predictors of vascular events in a high risk european population) study. J Am Coll Cardiol, 60, 1489–1499.

O'Leary, D. H., Polak, J. F, Kronma. I. R. A., et al. (1999). Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med, 340, 14–22.

Lorenz, M. W, Marku. s, H. S., Bots, M. L., et al. (2007). Prediction of clinical cardiovascular events with carotid intimamedia thickness: a systematic review and meta-analysis. Circulation, 115, 459–467.

Shoji, T., Kawagishi, T., Emoto M., et al. (2000). Additive impacts of diabetes and renal failure on carotid atherosclerosis. Atherosclerosis, 153, 257–258.

Yoshida, M., Mita, T., Yamamoto, R., et al. (2012). Combination of the Framingham risk score and carotid intima-media thickness improves the prediction of cardiovascular events in patients with type 2 diabetes. Diabetes Care, 35, 178–80.

Malik, S., Budof, M. J., Katz, R., et al. (2011). Impact of subclinical atherosclerosis on cardiovascular disease events in individuals with metabolic syndrome and diabetes: the multi-ethnic study of atherosclerosis. Diabetes Care, 34, 2285–90.

Katakami, N., Mita, T, . Gosho, M. (2018). Clinical utility of carotid ultrasonography in the prediction of cardiovascular events in patients with diabetes: a combined analysis of data obtained in fve longitudinal studies. J Atheroscler Thromb, 25, 1053–66.

Aronson, D., Edelman, E. R. (2014). Coronary artery disease and diabetes mellitus. Cardiology Clinics, 32(3), 439–455.

Cecilia, C., Wang, L. (2016). Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes – Mechanisms, Management, and Clinical Considerations. Circulation, 133(24), 2459–2502.

Citovs'kij, M. N., Statistichnij (2017). Klinichnna ta morfologichnij aspekti vplivu cukrovogo diabetu na stan sercevo-sudinnoi sistemi. Naukovij visnik Uzhgorods'kogo universitetu. Serija:Medicina, 1, 168–177.

Paneni, F, . Lischer, T.F. (2017). Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes. Am J Med, 130(6S), S18–S29.

Avogaro, A., Fadini, G.P, Sest. i, G., Bonora, E., Del Prato, S. (2016). Continued efforts to translate diabetes cardiovascular outcome trials into clinical practice. Cardiovasc Diabetol, 15, 111.

Brohall, G., Oden, A., Fagerberg, B. (2006). Carotid artery intima-media thickness in patients with type 2 diabetes mellitus and impaired glucose tolerance: a systematic review. Diabet Med, 23, 609–616.

Gomez-Marcos, M.A., Recio-Rodriguez, J.I., et al. ( 2011). Yearly evolution of organ damage markers in diabetes or metabolic syndrome: data from the LOD-DIABETES study. Cardiovasc Diabetol, 10, 90.

Boncler, M., Wu, Y., Watala, C. (2019). The Multiple Faces of C-Reactive Protein — Physiological and Pathophysiological Implications in Cardiovascular Disease. Molecules, 24(11), 2062. https://doi.org/10.3390/molecules24112062

Paffen, E., deMaat, M. P. M. (2006). C-reactive protein in atherosclerosis: A causal factor? Cardiovascular Research, 71(1), 30–39. https://doi.org/10.1016/j.cardiores.2006.03.004

Steyers, C. M., Miller, F. J. (2014). Endothelial dysfunction in chronic inflammatory diseases. Int J Mol Sci, 15, 11324-11349. PMID: 24968272. DOI: 10.3390/ijms150711324.

Szuszkiewicz-Garcia, M. M., Davidson, J. A. (2014). Cardiovascular disease in diabetes mellitus: risk factors and medical therapy. Endocrinol Metab Clin North Am, 43, 25-40. PMID: 24582090. DOI: 10.1016/j.ecl.2013.09.001.

"Inter Collegas" is an open access journal: all articles are published in open access without an embargo period, under the terms of the CC BY-NC-SA (Creative Commons Attribution ‒ Noncommercial ‒ Share Alike) license; the content is available to all readers without registration from the moment of its publication. Electronic copies of the archive of journals are placed in the repositories of the KhNMU and V.I. Vernadsky National Library of Ukraine.